mRNA booster works better than J&J's 2nd shot - report

Wednesday, 13. October 2021 05:44

People inoculated with the COVID-19 vaccine developed by Johnson & Johnson tend to develop more neutralizing antibodies after receiving a booster dose of one of the jabs based on the mRNA technology than those who receive an additional dose of J&J's single-shot vaccine, Axios reported, citing the National Institutes of Health data its source reviewed.

On the other hand, the level of neutralizing antibodies that an inoculated person amasses is not the only parameter that determines their immune response, the outlet warned.

Johnson & Johnson previously said it has asked the United States Food and Drug Administration (FDA) to authorize booster shots for its coronavirus vaccine, with the FDA expected to make the ruling later this week.

Related Links: Pfizer Inc.Johnson & Johnson
Breaking the News / BU